Sinopsis
New and exciting data presented each day during the conference and address the potential impact on current clinical practice.
Episodios
-
![Atopic Dermatitis Patients - Ages 2-5 (Moderate-Severe Disease) - Amy Paller, MS, MD]()
Atopic Dermatitis Patients - Ages 2-5 (Moderate-Severe Disease) - Amy Paller, MS, MD
20/12/2019 Duración: 43minAtopic Dermatitis: Real-World Strategies to Improve Outcomes
-
![Atopic Dermatitis Patients - Ages 2-5 (Mild-Moderate Disease) - Amy Paller, MS, MD]()
Atopic Dermatitis Patients - Ages 2-5 (Mild-Moderate Disease) - Amy Paller, MS, MD
20/12/2019 Duración: 32minAtopic Dermatitis: Real-World Strategies to Improve Outcomes
-
![Atopic Dermatitis Patients - Ages 0-2 (Moderate-Severe Disease) - Albert C. Yan, MD, FAAP, FAAD]()
Atopic Dermatitis Patients - Ages 0-2 (Moderate-Severe Disease) - Albert C. Yan, MD, FAAP, FAAD
20/12/2019 Duración: 34minAtopic Dermatitis: Real-World Strategies to Improve Outcomes
-
![Atopic Dermatitis Patients - Ages 0-2 (Mild-Moderate Disease) - Albert C. Yan, MD, FAAP, FAAD]()
Atopic Dermatitis Patients - Ages 0-2 (Mild-Moderate Disease) - Albert C. Yan, MD, FAAP, FAAD
20/12/2019 Duración: 36minAtopic Dermatitis: Real-World Strategies to Improve Outcomes
-
![Panel Discussion: CAR-T in Myeloma - James R. Berenson, MD Sham Mailankody, MBBS Deepu Madduri, MD Adam D. Cohen, MD]()
Panel Discussion: CAR-T in Myeloma - James R. Berenson, MD; Sham Mailankody, MBBS; Deepu Madduri, MD; Adam D. Cohen, MD
20/12/2019 Duración: 07minMultiple Myeloma: Treatment Challenges and Updates
-
![CAR-Ts: What are the Next Generation Products and Strategies? Upfront, High Risk? - Adam D. Cohen, MD]()
CAR-Ts: What are the Next Generation Products and Strategies? Upfront, High Risk? - Adam D. Cohen, MD
20/12/2019 Duración: 21minMultiple Myeloma: Treatment Challenges and Updates
-
![Dealing with Adverse Events and Toxicities in CAR-T - Deepu Madduri, MD]()
Dealing with Adverse Events and Toxicities in CAR-T - Deepu Madduri, MD
20/12/2019 Duración: 22minMultiple Myeloma: Treatment Challenges and Updates
-
![Responses to CAR-T Therapy in Myeloma - Sham Mailankody, MBBS]()
Responses to CAR-T Therapy in Myeloma - Sham Mailankody, MBBS
20/12/2019 Duración: 17minMultiple Myeloma: Treatment Challenges and Updates
-
![Myeloma: New Drugs on the Horizon - Kenneth C. Anderson, MD]()
Myeloma: New Drugs on the Horizon - Kenneth C. Anderson, MD
20/12/2019 Duración: 20minMultiple Myeloma: Treatment Challenges and Updates
-
![What is the Best Treatment Approach for Patients who are Not Transplant Eligible - S. Vincent Rajkumar, MD]()
What is the Best Treatment Approach for Patients who are Not Transplant Eligible - S. Vincent Rajkumar, MD
20/12/2019 Duración: 15minMultiple Myeloma: Treatment Challenges and Updates
-
![What is the Best Approach for the Relapsing Patient: Does P53 Matter? - Shaji K. Kumar, MD]()
What is the Best Approach for the Relapsing Patient: Does P53 Matter? - Shaji K. Kumar, MD
20/12/2019 Duración: 19minMultiple Myeloma: Treatment Challenges and Updates
-
![Treatment for the Transplant Eligible Patients: Doublets-Triplets? - Adriana Rossi, MD]()
Treatment for the Transplant Eligible Patients: Doublets-Triplets? - Adriana Rossi, MD
20/12/2019 Duración: 17minMultiple Myeloma: Treatment Challenges and Updates
-
![Debate: Treatment of Smoldering Myeloma: What Treatment is Ideal? - C. Ola Landgren, MD, PhD and Joseph R. Mikhael, MD, MEd, FRCPC]()
Debate: Treatment of Smoldering Myeloma: What Treatment is Ideal? - C. Ola Landgren, MD, PhD and Joseph R. Mikhael, MD, MEd, FRCPC
20/12/2019 Duración: 29minMultiple Myeloma: Treatment Challenges and Updates
-
![Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD]()
Antibodies in Practice: SLAMF-7, CD38, Bispecific? Updates: Should They be Used Upfront? - Ajai Chari, MD
20/12/2019 Duración: 22minMultiple Myeloma: Treatment Challenges and Updates
-
![Role of BCMA in Predicting Outcomes and Monitoring MM and CLL - James R. Berenson, MD]()
Role of BCMA in Predicting Outcomes and Monitoring MM and CLL - James R. Berenson, MD
20/12/2019 Duración: 20minMultiple Myeloma: Treatment Challenges and Updates
-
![Panel Discussion: Precision Medicine in Myeloma - Gareth J. Morgan, MD Angela Dispenzieri, MD Rafael Fonseca, MD Jens Hillengass, MD]()
Panel Discussion: Precision Medicine in Myeloma - Gareth J. Morgan, MD; Angela Dispenzieri, MD; Rafael Fonseca, MD; Jens Hillengass, MD
20/12/2019 Duración: 12minMultiple Myeloma: Treatment Challenges and Updates
-
![Use of Novel Imaging Techniques in Evaluating Myeloma at Presentation, Relapse, and MRD - Jens Hillengass, MD]()
Use of Novel Imaging Techniques in Evaluating Myeloma at Presentation, Relapse, and MRD - Jens Hillengass, MD
20/12/2019 Duración: 19minMultiple Myeloma: Treatment Challenges and Updates
-
![Minimal Residual Disease Detection, Single Cell RNA Seq., Cell Free DNA, etc: Does it Impact Treatment? - Rafael Fonseca, MD]()
Minimal Residual Disease Detection, Single Cell RNA Seq., Cell Free DNA, etc: Does it Impact Treatment? - Rafael Fonseca, MD
20/12/2019 Duración: 18minMultiple Myeloma: Treatment Challenges and Updates
-
![Clinical Use of Mass Spectrometry in Measuring Myeloma - Angela Dispenzieri, MD]()
Clinical Use of Mass Spectrometry in Measuring Myeloma - Angela Dispenzieri, MD
20/12/2019 Duración: 20minMultiple Myeloma: Treatment Challenges and Updates
-
![Deep Sequencing: Would it Change Treatment? Does it Really Help? - Gareth J. Morgan, MD]()
Deep Sequencing: Would it Change Treatment? Does it Really Help? - Gareth J. Morgan, MD
20/12/2019 Duración: 20minMultiple Myeloma: Treatment Challenges and Updates
